SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

Combining talazoparib with enzalutamide significantly improves overall survival in patients with metastatic ...

A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted treatments with fewer “awful” side effects.

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

Progression-free survival (PFS) in oligometastatic prostate cancer improved significantly with metastasis-directed therapy ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and ...

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer to improve screening, diagnosis and ...

The latest figures on prostate cancer are shocking: it has officially overtaken breast cancer as the most commonly diagnosed ...

About half of men with medium-risk prostate cancer have just one tumour, occupying only 5 to 10 per cent of the prostate, yet ...

SCIENTISTS have a developed a “game-changing” new “super test” that can diagnose prostate cancer with 96 per cent accuracy.

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Dr Matthew Hobbs, director of research at Prostate Cancer UK, said there is an urgent need for better prostate cancer testing ...